Arvinas

Arvinas

CT - New Haven
Biotechnology2 H-1B visas (FY2023)

Focus: Bifunctional small molecules for protein degradation

Arvinas is a life sciences company focused on Bifunctional small molecules for protein degradation.

Oncology
Open Jobs
4

Pipeline & Clinical Trials

Phase 1
vepdegestrant
Healthy
Phase 1
Phase 1
single dose of vepdegestrant as tablet formulation
Healthy
Phase 1
vepdegestrant
Healthy
Phase 1
Clinical Trials (1)
NCT06275841A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine Vepdegestrant
Phase 1
ARV-110 in Combination with Abiraterone
Prostate Cancer Metastatic
Phase 1
Clinical Trials (1)
NCT05177042Trial of ARV-110 and Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Phase 1
Phase 1
Clinical Trials (1)
NCT06393738A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
Phase 1
Phase 1
ARV-471 in combination with Everolimus
Breast Cancer
Phase 1
ARV-471
Healthy
Phase 1
Phase 1
vepdegestrant
Breast Neoplasms
Phase 1
Clinical Trials (1)
NCT05463952A Study to Learn About the Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (BC)
Phase 1
single dose of vepdegestrant as tablet formulation
Healthy
Phase 1
Clinical Trials (1)
NCT06347861A Study to Learn How Various Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood of Healthy Adults
Phase 1
[phenyl-14C]ARV-471
Healthy
Phase 1
ARV-471
Healthy
Phase 1
Phase 1/2
vepdegestrant
Breast Cancer
Phase 1/2
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT07023731A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Phase 1/2
Clinical Trials (1)
NCT03888612Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer
Phase 1/2
Phase 1/2
vepdegestrant
Breast Cancer
Phase 1/2
Phase 2
Vepdegestrant
Breast Cancer
Phase 3

Open Jobs (4)

Interview Prep Quick Facts
Portfolio: 7 clinical trials
H-1B (2023): 2 approvals
Open Roles: 4 active jobs

Hiring Trend

Stable
4
Open Roles
+3
Added
-1
Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
2
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub